Synthesis, crystal structure and cytotoxic activity of novel 5-methyl-4-thiopyrimidine derivatives

Marcin Stolarczyk , Iwona Bryndal , Agnieszka Matera-Witkiewicz , Tadeusz Lis , Karolina Królewska-Golińska , Marcin Ciesślak , Julia Kaźmierczak-Barańska , Jerzy Cieplik


This article presents the synthesis of three new 4-thiopyrimidine derivatives obtained from ethyl 4-methyl-2-phenyl-6-sulfanylpyrimidine-5-carboxylate as the starting material, namely, ethyl 4-[(4-chlorobenzyl)sulfanyl]-6-methyl-2-phenylpyrimidine-5-carboxylate, C21H19ClN2O2S, (2), {4-[(4-chlorobenzyl)sulfanyl]-6-methyl-2-phenylpyrimidin-5-yl}methanol, C19H17ClN2OS, (3), and 4-[(4-chlorobenzyl)sulfanyl]-5,6-dimethyl-2-phenylpyrimidine, C19H17ClN2S, (4), which vary in the substituent at the 5-position of the pyrimidine ring. The compounds were characterized by 1H NMR, 13C NMR, IR and mass spectroscopies, and also elemental analysis. The molecular structures were further studied by single-crystal X-ray diffraction. Compound (2) crystallizes in the space group P-1 with one molecule in the asymmetric unit, whereas compounds (3) and (4) crystallize in the space group P21/c with two and one molecule, respectively, in their asymmetric units. The conformation of each molecule is best defined by the dihedral angles formed between the pyrimidine ring and the planes of the two aryl substituents attached at the 2- and 4-positions. The only structural difference between the three compounds is the substituent at the 5-position of the pyrimidine ring, but they present significantly different features in the hydrogen-bond interactions. Compound (2) displays a one-dimensional chain formed by hydrogen bonds and the chains are further extended into a two-dimensional network. Molecules of (3) and (4) generate one-dimensional chains formed through intermolecular interactions. The study examines the cytotoxicity of compounds (3) and (4) against Human umbilical vein endothelial cells (HUVEC) and HeLa, K562 and CFPAC cancer cell lines. The presence of the hydroxymethyl and methyl groups in (3) and (4), respectively, offers an interesting new insight into the structures and behaviour of these derivatives. Compound (4) was found to be nontoxic against CFPAC and HUVEC; however, it shows weak activity against the HeLa and K563 cell lines. The presence of a hydroxy group in (3) significantly increases its cytotoxicity towards both, i.e. the cancer (HeLa, K562 and CFPAC) and normal (HUVEC) cell lines.
Author Marcin Stolarczyk
Marcin Stolarczyk,,
, Iwona Bryndal (EaE / IChaFT / DBCh)
Iwona Bryndal,,
- Department of Bioorganic Chemistry
, Agnieszka Matera-Witkiewicz
Agnieszka Matera-Witkiewicz,,
, Tadeusz Lis - University of Wrocław (UWr)
Tadeusz Lis,,
, Karolina Królewska-Golińska
Karolina Królewska-Golińska,,
, Marcin Ciesślak
Marcin Ciesślak,,
, Julia Kaźmierczak-Barańska
Julia Kaźmierczak-Barańska,,
, Jerzy Cieplik
Jerzy Cieplik,,
Journal seriesActa Crystallographica Section C-Structural Chemistry, [Acta crystallographica. Section C, Structural chemistry], ISSN 2053-2296, (A 15 pkt)
Issue year2018
Publication size in sheets0.5
Keywords in English4-thiopyrimidine derivatives, crystal structure, cytotoxic activity, synthesis
ASJC Classification1604 Inorganic Chemistry; 1606 Physical and Theoretical Chemistry; 2505 Materials Chemistry; 3104 Condensed Matter Physics
Languageen angielski
Score (nominal)15
Score sourcejournalList
Publication indicators Scopus SNIP (Source Normalised Impact per Paper): 2016 = 1.523; WoS Impact Factor: 2017 = 8.678 (2) - 2017=2.956 (5)
Citation count*
Share Share

Get link to the record

* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.